Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fraction.

Nishihara T, Yamamoto E, Sueta D, Fujisue K, Usuku H, Oike F, Takae M, Arima Y, Araki S, Takashio S, Nakamura T, Suzuki S, Sakamoto K, Soejima H, Kawano H, Kaikita K, Tsujita K.

Medicine (Baltimore). 2019 Sep;98(38):e17069. doi: 10.1097/MD.0000000000017069.

2.

Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction.

Fujisue K, Tokitsu T, Yamamoto E, Sueta D, Takae M, Nishihara T, Oike F, Usuku H, Ito M, Motozato K, Kanazawa H, Araki S, Arima Y, Takashio S, Izumiya Y, Suzuki S, Sakamoto K, Kaikita K, Tsujita K.

Medicine (Baltimore). 2019 Jul;98(28):e15959. doi: 10.1097/MD.0000000000015959.

3.

H2FPEF Score as a Prognostic Value in HFpEF Patients.

Sueta D, Yamamoto E, Nishihara T, Tokitsu T, Fujisue K, Oike F, Takae M, Usuku H, Takashio S, Arima Y, Suzuki S, Nakamura T, Ito M, Kanazawa H, Sakamoto K, Kaikita K, Tsujita K.

Am J Hypertens. 2019 Oct 16;32(11):1082-1090. doi: 10.1093/ajh/hpz108.

PMID:
31271191
4.

Development of caseous calcification of mitral annulus after initiation of hemodialysis therapy.

Usuku H, Yamamoto E, Oike F, Tsunoda R, Nishigami K, Sakaguchi T, Suzuki R, Uekihara S, Matsui H, Tsujita K.

J Cardiol Cases. 2019 Mar 8;19(6):190-193. doi: 10.1016/j.jccase.2019.02.002. eCollection 2019 Jun.

5.

Clinical Significance of Brachial-Ankle Pulse Wave Velocity in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction.

Takae M, Yamamoto E, Tokitsu T, Oike F, Nishihara T, Fujisue K, Sueta D, Usuku H, Motozato K, Ito M, Kanazawa H, Araki S, Nakamura T, Arima Y, Takashio S, Suzuki S, Sakamoto K, Soejima H, Yamabe H, Kaikita K, Tsujita K.

Am J Hypertens. 2019 Jun 11;32(7):657-667. doi: 10.1093/ajh/hpz048.

PMID:
31090886
6.

Coronary blood flow volume change is negatively associated with platelet aggregability in patients with non-obstructive ischemic heart disease who have no anti-platelet agents.

Takae M, Yamamoto E, Fujisue K, Oike F, Nishihara T, Sueta D, Usuku H, Motozato K, Ito M, Hanatani S, Kanazawa H, Arima Y, Takashio S, Nakamura T, Suzuki S, Sakamoto K, Izumiya Y, Soejima H, Kojima S, Yamabe H, Kaikita K, Tsujita K.

Int J Cardiol. 2019 Feb 15;277:3-7. doi: 10.1016/j.ijcard.2018.08.068. Epub 2018 Aug 24.

PMID:
30173925
7.

Serum Potassium and Cardiovascular Events in Heart Failure With Preserved Left Ventricular Ejection Fraction Patients.

Nishihara T, Tokitsu T, Sueta D, Takae M, Oike F, Fujisue K, Usuku H, Takashio S, Hanatani S, Kanazawa H, Arima Y, Sakamoto K, Izumiya Y, Yamabe H, Kaikita K, Yamamoto E, Tsujita K.

Am J Hypertens. 2018 Sep 11;31(10):1098-1105. doi: 10.1093/ajh/hpy101.

PMID:
29985986
8.

Clinical significance of brachial-ankle pulse-wave velocity in patients with heart failure with preserved left ventricular ejection fraction.

Tokitsu T, Yamamoto E, Oike F, Hirata Y, Tsujita K, Yamamuro M, Kaikita K, Hokimoto S.

J Hypertens. 2018 Mar;36(3):560-568. doi: 10.1097/HJH.0000000000001589.

PMID:
29084082
9.

Protocol for laparoscopic cholecystectomy: Is it rocket science?

Hori T, Oike F, Furuyama H, Machimoto T, Kadokawa Y, Hata T, Kato S, Yasukawa D, Aisu Y, Sasaki M, Kimura Y, Takamatsu Y, Naito M, Nakauchi M, Tanaka T, Gunji D, Nakamura K, Sato K, Mizuno M, Iida T, Yagi S, Uemoto S, Yoshimura T.

World J Gastroenterol. 2016 Dec 21;22(47):10287-10303. doi: 10.3748/wjg.v22.i47.10287. Review.

10.

Prospective registry for laparoscopic liver resection.

Fuji H, Hatano E, Seo S, Arimoto A, Okabe M, Fujikawa T, Nishitai R, Ishii T, Kaihara S, Matsushita T, Oike F, Ichimiya M, Ohta S, Yamanaka K, Taura K, Yasuchika K, Uemoto S.

Asian J Endosc Surg. 2017 May;10(2):173-178. doi: 10.1111/ases.12351. Epub 2016 Dec 14.

PMID:
27976516
11.

Graft harvest of right posterior segment for living-donor liver transplantation.

Hori T, Oike F, Ogura Y, Ogawa K, Uemoto S.

Int J Surg Case Rep. 2014;5(8):516-22. doi: 10.1016/j.ijscr.2014.04.015. Epub 2014 Jun 2.

12.

Usefulness of endoscope guided transabdominal ultrasonography in T staging of colorectal cancer.

Seo S, Hamaguchi Y, Okuda Y, Arimitsu T, Babazono Y, Tanaka J, Sugimoto H, Takimoto Y, Hirai Y, Ueda S, Ota T, Fujimoto Y, Oike F, Mitsuyosh A.

Hepatogastroenterology. 2013 Oct;60(127):1627-32.

PMID:
24634933
13.

Hematogenous umbilical metastasis from colon cancer treated by palliative single-incision laparoscopic surgery.

Hori T, Okada N, Nakauchi M, Hiramoto S, Kikuchi-Mizota A, Kyogoku M, Oike F, Sugimoto H, Tanaka J, Morikami Y, Shigemoto K, Ota T, Kaneko M, Nakatsuji M, Okae S, Tanaka T, Gunji D, Yoshioka A.

World J Gastrointest Surg. 2013 Oct 27;5(10):272-7. doi: 10.4240/wjgs.v5.i10.272.

14.

Laparoscopic-assisted catheter insertion for continuous ambulatory peritoneal dialysis: A case report of simple technique for optimal placement.

Hori T, Nakauchi M, Nagao K, Oike F, Tanaka T, Gunji D, Okada N.

World J Gastrointest Surg. 2013 Oct 27;5(10):268-71. doi: 10.4240/wjgs.v5.i10.268.

15.

Cytokine gene polymorphisms in acute cellular rejection following living donor liver transplantation: analysis of 155 donor-recipient pairs.

Kamei H, Masuda S, Nakamura T, Ishigami M, Fujimoto Y, Ogura Y, Oike F, Takada Y, Hamajima N.

Hepatol Int. 2013 Jul;7(3):916-22. doi: 10.1007/s12072-013-9443-2. Epub 2013 Jul 31.

PMID:
26201930
16.
17.

Impact of glutathione S-transferase T1 gene polymorphisms on acute cellular rejection in living donor liver transplantation.

Kamei H, Masuda S, Nakamura T, Fujimoto Y, Oike F, Ogura Y, Takada Y, Hamajima N.

Transpl Immunol. 2013 Jan;28(1):14-7. doi: 10.1016/j.trim.2012.11.002. Epub 2012 Nov 12.

PMID:
23153768
18.

Long-term quality of life of donors after living donor liver transplantation.

Takada Y, Suzukamo Y, Oike F, Egawa H, Morita S, Fukuhara S, Uemoto S, Tanaka K.

Liver Transpl. 2012 Nov;18(11):1343-52. doi: 10.1002/lt.23509.

19.

Surgical text for orthotopic liver transplantation model with small-for-size graft in the pig: key techniques and pitfalls.

Hori T, Yagi S, Iida T, Taniguchi K, Yamamoto C, Sakakura R, Nakamura K, Uryuhara K, Oike F, Uemto S.

Ann Gastroenterol. 2012;25(2):147-161.

20.

De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.

Ueda Y, Marusawa H, Egawa H, Okamoto S, Ogura Y, Oike F, Nishijima N, Takada Y, Uemoto S, Chiba T.

Antivir Ther. 2011;16(4):479-87. doi: 10.3851/IMP1771.

PMID:
21685535
21.

Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.

Hori T, Kaido T, Oike F, Ogura Y, Ogawa K, Yonekawa Y, Hata K, Kawaguchi Y, Ueda M, Mori A, Segawa H, Yurugi K, Takada Y, Egawa H, Yoshizawa A, Kato T, Saito K, Wang L, Torii M, Chen F, Baine AM, Gardner LB, Uemoto S.

World J Gastroenterol. 2011 Apr 14;17(14):1848-57. doi: 10.3748/wjg.v17.i14.1848.

22.

Impact of pretransplant nutritional status in patients undergoing liver transplantation.

Kaido T, Mori A, Oike F, Mizumoto M, Ogura Y, Hata K, Yoshizawa A, Iida T, Uemoto S.

Hepatogastroenterology. 2010 Nov-Dec;57(104):1489-92.

PMID:
21443108
23.

Progressive familial intrahepatic cholestasis: a single-center experience of living-donor liver transplantation during two decades in Japan.

Hori T, Egawa H, Takada Y, Ueda M, Oike F, Ogura Y, Sakamoto S, Kasahara M, Ogawa K, Miyagawa-Hayashino A, Yonekawa Y, Yorifuji T, Watanabe K, Doi H, Nguyen JH, Chen F, Baine AM, Gardner LB, Uemoto S.

Clin Transplant. 2011 Sep-Oct;25(5):776-85. doi: 10.1111/j.1399-0012.2010.01368.x. Epub 2010 Dec 16.

PMID:
21158920
24.

Effect of maintenance therapy with low-dose peginterferon for recurrent hepatitis C after living donor liver transplantation.

Ueda Y, Marusawa H, Kaido T, Ogura Y, Oike F, Mori A, Ogawa K, Yoshizawa A, Hatano E, Miyagawa-Hayashino A, Haga H, Egawa H, Takada Y, Uemoto S, Chiba T.

J Viral Hepat. 2012 Jan;19(1):32-8. doi: 10.1111/j.1365-2893.2010.01398.x. Epub 2010 Dec 3.

PMID:
21129128
25.

Posttransplant bacteremia in adult living donor liver transplant recipients.

Iida T, Kaido T, Yagi S, Yoshizawa A, Hata K, Mizumoto M, Mori A, Ogura Y, Oike F, Uemoto S.

Liver Transpl. 2010 Dec;16(12):1379-85. doi: 10.1002/lt.22165.

26.

Liver transplantation for congenital biliary dilatation: a single-center experience.

Hori T, Oike F, Ogura Y, Ogawa K, Hata K, Yonekawa Y, Ueda M, Sakamoto S, Kasahara M, Egawa H, Takada Y, Kaido T, Hatano E, Nguyen JH, Chen F, Baine AM, Uemoto S.

Dig Surg. 2010;27(6):492-501. doi: 10.1159/000319373. Epub 2010 Nov 10.

PMID:
21063126
27.

Graft loss and poor outcomes after living-donor liver transplantation owing to arterioportal shunts caused by liver needle biopsies.

Hori T, Ueda M, Oike F, Ogura Y, Ogawa K, Nguyen JH, Yonekawa Y, Takada Y, Egawa H, Yoshizawa A, Sibulesky L, Balci D, Chen F, Baine AM, Uemoto S.

Transplant Proc. 2010 Sep;42(7):2642-4. doi: 10.1016/j.transproceed.2010.04.032.

28.

Long-term outcomes after living-donor liver transplantation for Alagille syndrome: a single center 20-year experience in Japan.

Hori T, Egawa H, Takada Y, Oike F, Kasahara M, Ogura Y, Sakamoto S, Ogawa K, Yonekawa Y, Nguyen JH, Doi H, Ueno M, Uemoto S.

Am J Transplant. 2010 Aug;10(8):1951-2. doi: 10.1111/j.1600-6143.2010.03196.x. No abstract available.

29.

Comprehensive and innovative techniques for liver transplantation in rats: a surgical guide.

Hori T, Nguyen JH, Zhao X, Ogura Y, Hata T, Yagi S, Chen F, Baine AM, Ohashi N, Eckman CB, Herdt AR, Egawa H, Takada Y, Oike F, Sakamoto S, Kasahara M, Ogawa K, Hata K, Iida T, Yonekawa Y, Sibulesky L, Kuribayashi K, Kato T, Saito K, Wang L, Torii M, Sahara N, Kamo N, Sahara T, Yasutomi M, Uemoto S.

World J Gastroenterol. 2010 Jul 7;16(25):3120-32.

30.

Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before.

Ogura Y, Hori T, El Moghazy WM, Yoshizawa A, Oike F, Mori A, Kaido T, Takada Y, Uemoto S.

Liver Transpl. 2010 Jun;16(6):718-28. doi: 10.1002/lt.22059.

31.

Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epstein-Barr virus infection.

Hori T, Oike F, Hata K, Nishikiori M, Ogura Y, Ogawa K, Takada Y, Egawa H, Nguyen JH, Uemoto S.

Transpl Infect Dis. 2010 Aug 1;12(4):347-52. doi: 10.1111/j.1399-3062.2010.00508.x. Epub 2010 Apr 26.

PMID:
20456713
32.

The rare insertion of b4 with trifurcated portal vein in live donor.

Iida T, Kaido T, Mori A, Nagata H, Hata K, Koizumi M, Mizumoto M, Ogura Y, Oike F, Uemoto S.

Transplantation. 2010 May 15;89(9):1163-4. doi: 10.1097/TP.0b013e3181d2feac. No abstract available.

PMID:
20440197
33.

Surgery-related morbidity in living donors for liver transplantation.

Iida T, Ogura Y, Oike F, Hatano E, Kaido T, Egawa H, Takada Y, Uemoto S.

Transplantation. 2010 May 27;89(10):1276-82. doi: 10.1097/TP.0b013e3181d66c55.

PMID:
20216482
34.

Pediatric orthotopic living-donor liver transplantation cures pulmonary hypertension caused by Abernethy malformation type Ib.

Hori T, Yonekawa Y, Okamoto S, Ogawa K, Ogura Y, Oike F, Takada Y, Egawa H, Nguyen JH, Uemoto S.

Pediatr Transplant. 2011 May;15(3):e47-52. doi: 10.1111/j.1399-3046.2009.01269.x.

PMID:
20136726
35.

Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?

Hori T, Uemoto S, Takada Y, Oike F, Ogura Y, Ogawa K, Miyagawa-Hayashino A, Yurugi K, Nguyen JH, Hori Y, Chen F, Egawa H.

Surgery. 2010 Jun;147(6):840-4. doi: 10.1016/j.surg.2009.11.022. Epub 2010 Jan 21.

36.

Herpes simplex virus hepatitis after pediatric liver transplantation.

Hori T, Ogura Y, Okamoto S, Nakajima A, Kami K, Iwasaki J, Yonekawa Y, Ogawa K, Oike F, Takada Y, Egawa H, Nguyen JH, Uemoto S.

Transpl Infect Dis. 2010 Aug 1;12(4):353-7. doi: 10.1111/j.1399-3062.2009.00486.x. Epub 2009 Dec 20.

PMID:
20030795
37.

Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study.

Hosohata K, Masuda S, Yonezawa A, Sugimoto M, Takada Y, Kaido T, Ogura Y, Oike F, Uemoto S, Inui K.

Drug Metab Pharmacokinet. 2009;24(5):458-63.

38.

Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation.

Hori T, Egawa H, Takada Y, Oike F, Ogura Y, Ogawa K, Kaido T, Toshimitsu Y, Yagi S, Iida T, Nguyen JH, Uemoto S.

Transpl Int. 2010 Mar 1;23(3):338-40. doi: 10.1111/j.1432-2277.2009.00954.x. Epub 2009 Sep 2. No abstract available.

39.

Mesorenal shunt using inferior mesenteric vein and left renal vein in a case of LDLT.

Kanazawa H, Takada Y, Ogura Y, Oike F, Egawa H, Uemoto S.

Transpl Int. 2009 Dec;22(12):1189-92. doi: 10.1111/j.1432-2277.2009.00928.x. Epub 2009 Jul 20.

40.

Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma.

Fujiki M, Takada Y, Ogura Y, Oike F, Kaido T, Teramukai S, Uemoto S.

Am J Transplant. 2009 Oct;9(10):2362-71. doi: 10.1111/j.1600-6143.2009.02783.x. Epub 2009 Jul 29.

41.

MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patients.

Hosohata K, Masuda S, Yonezawa A, Katsura T, Oike F, Ogura Y, Takada Y, Egawa H, Uemoto S, Inui K.

Pharm Res. 2009 Jul;26(7):1590-5. doi: 10.1007/s11095-009-9867-5. Epub 2009 Mar 7.

PMID:
19267185
42.

Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation.

Yoshitoshi EY, Takada Y, Oike F, Sakamoto S, Ogawa K, Kanazawa H, Ogura Y, Okamoto S, Haga H, Ueda M, Egawa H, Kasahara M, Tanaka K, Uemoto S.

Transplantation. 2009 Jan 27;87(2):261-7. doi: 10.1097/TP.0b013e3181919984.

PMID:
19155982
43.

Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients.

Hosohata K, Masuda S, Katsura T, Takada Y, Kaido T, Ogura Y, Oike F, Egawa H, Uemoto S, Inui K.

Drug Metab Dispos. 2009 Apr;37(4):821-6. doi: 10.1124/dmd.108.025833. Epub 2009 Jan 12.

PMID:
19139162
44.

Impact of preexisting circulating effector T cells on the outcome of ABO-incompatible adult LDLT.

Egawa H, Ozawa K, Takada Y, Teramukai S, Mori A, Kasahara M, Ogawa K, Ogura Y, Oike F, Kaido T, Ono M, Sato H, Takai K, Uemoto S.

Dig Dis Sci. 2009 Oct;54(10):2253-63. doi: 10.1007/s10620-008-0618-y. Epub 2008 Dec 11.

PMID:
19082716
45.

Successful stent placement for hepatic venous outflow obstruction in pediatric living donor liver transplantation, including a case series review.

Sakamoto S, Ogura Y, Shibata T, Haga H, Ogawa K, Oike F, Ueda M, Egawa H, Takada Y, Uemoto S.

Pediatr Transplant. 2009 Jun;13(4):507-11. doi: 10.1111/j.1399-3046.2008.01003.x. Epub 2008 Oct 7.

PMID:
18992045
46.

Required transient dose escalation of tacrolimus in living-donor liver transplant recipients with high concentrations of a minor metabolite M-II in bile.

Shimomura M, Masuda S, Goto M, Katsura T, Kiuchi T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K.

Drug Metab Pharmacokinet. 2008;23(5):313-7.

47.

Portal vein complications in pediatric living donor liver transplantation using left-side grafts.

Ueda M, Oike F, Kasahara M, Ogura Y, Ogawa K, Haga H, Takada Y, Egawa H, Tanaka K, Uemoto S.

Am J Transplant. 2008 Oct;8(10):2097-105. doi: 10.1111/j.1600-6143.2008.02360.x. Epub 2008 Aug 22.

48.

Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5.

Hosohata K, Masuda S, Ogura Y, Oike F, Takada Y, Katsura T, Uemoto S, Inui K.

Drug Metab Pharmacokinet. 2008;23(2):134-8.

49.

Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.

Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K, Katsura T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K.

Pharmacogenet Genomics. 2008 May;18(5):413-23. doi: 10.1097/FPC.0b013e3282f9ac01.

PMID:
18408564
50.

Current status of liver transplantation across ABO blood-type barrier.

Egawa H, Ohdan H, Haga H, Tsuruyama T, Oike F, Uemoto S, Ozawa K.

J Hepatobiliary Pancreat Surg. 2008;15(2):131-8. doi: 10.1007/s00534-007-1298-2. Epub 2008 Apr 6.

PMID:
18392705

Supplemental Content

Support Center